文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

青少年良性复发性肝内胆汁淤积症与心理社会应激源的诊断和管理:一例报告

Diagnosis and management of benign recurrent intrahepatic cholestasis and psychosocial stressors in an adolescent: A case report.

作者信息

Xu Ya-Xin, Niu Xiao-Xuan, Xu Bei-Li, Ji Yuan, Yao Qun-Yan

机构信息

Department of General Practice, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Department of Nutrition, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

出版信息

World J Clin Cases. 2024 Jul 16;12(20):4427-4433. doi: 10.12998/wjcc.v12.i20.4427.


DOI:10.12998/wjcc.v12.i20.4427
PMID:39015910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11235557/
Abstract

BACKGROUND: Benign recurrent intrahepatic cholestasis (BRIC) is a rare autosomal recessive disorder, characterized by episodes of intense pruritus, elevated serum levels of alkaline phosphatase and bilirubin, and near-normal -glutamyl transferase. These episodes may persist for weeks to months before spontaneously resolving, with patients typically remaining asymptomatic between occurrences. Diagnosis entails the evaluation of clinical symptoms and targeted genetic testing. Although BRIC is recognized as a benign genetic disorder, the triggers, particularly psychosocial factors, remain poorly understood. CASE SUMMARY: An 18-year-old Chinese man presented with recurrent jaundice and pruritus after a cold, which was exacerbated by self-medication involving vitamin B and paracetamol. Clinical and laboratory evaluations revealed elevated levels of bilirubin and liver enzymes, in the absence of viral or autoimmune liver disease. Imaging excluded biliary and pancreatic abnormalities, and liver biopsy demonstrated centrilobular cholestasis, culminating in a BRIC diagnosis confirmed by the identification of a novel gene mutation. Psychological assessment of the patient unveiled stress attributable to academic and familial pressures, regarded as potential triggers for BRIC. Initial relief was observed with ursodeoxycholic acid and cetirizine, followed by an adjustment of the treatment regimen in response to elevated liver enzymes. The patient's condition significantly improved following a stress-related episode, thanks to a comprehensive management approach that included psychosocial support and medical treatment. CONCLUSION: Our research highlights genetic and psychosocial influences on BRIC, emphasizing integrated diagnostic and management strategies.

摘要

背景:良性复发性肝内胆汁淤积症(BRIC)是一种罕见的常染色体隐性疾病,其特征为剧烈瘙痒发作、血清碱性磷酸酶和胆红素水平升高,以及γ-谷氨酰转移酶接近正常。这些发作可能持续数周或数月后自行缓解,患者在发作间期通常无症状。诊断需要评估临床症状并进行针对性基因检测。尽管BRIC被认为是一种良性遗传病,但其触发因素,尤其是心理社会因素,仍知之甚少。 病例摘要:一名18岁中国男性在感冒后出现反复黄疸和瘙痒,自行服用维生素B和对乙酰氨基酚后病情加重。临床和实验室评估显示胆红素和肝酶水平升高,排除了病毒性或自身免疫性肝病。影像学检查排除了胆道和胰腺异常,肝活检显示小叶中心性胆汁淤积,最终通过鉴定一种新的基因突变确诊为BRIC。对患者的心理评估发现,学业和家庭压力导致的应激被认为是BRIC的潜在触发因素。熊去氧胆酸和西替利嗪治疗后症状初步缓解,随后根据肝酶升高情况调整治疗方案。在一次与应激相关的发作后,由于采取了包括心理社会支持和药物治疗在内的综合管理方法,患者病情显著改善。 结论:我们的研究强调了基因和心理社会因素对BRIC的影响,强调了综合诊断和管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef76/11235557/782c746ab652/WJCC-12-4427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef76/11235557/a6a379c38ab9/WJCC-12-4427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef76/11235557/782c746ab652/WJCC-12-4427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef76/11235557/a6a379c38ab9/WJCC-12-4427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef76/11235557/782c746ab652/WJCC-12-4427-g002.jpg

相似文献

[1]
Diagnosis and management of benign recurrent intrahepatic cholestasis and psychosocial stressors in an adolescent: A case report.

World J Clin Cases. 2024-7-16

[2]
Case Report: A Novel Single Variant TJP2 Mutation in a Case of Benign Recurrent Intrahepatic Cholestasis.

JPGN Rep. 2021-6-25

[3]
Nonsense variant of gene in heterozygosis and benign recurrent intrahepatic cholestasis: A case report and review of literature.

World J Hepatol. 2020-2-27

[4]
Benign Recurrent Intrahepatic Cholestasis Type 1 with Novel Nonsense Mutations in the Gene.

Case Rep Gastroenterol. 2022-3-4

[5]
Case Report: A Rare Case of Benign Recurrent Intrahepatic Cholestasis-Type 1 With a Novel Heterozygous Pathogenic Variant of .

Front Med (Lausanne). 2022-4-29

[6]
Endoscopic nasobiliary drainage: an effective treatment option for benign recurrent intrahepatic cholestasis (BRIC).

BMJ Case Rep. 2017-5-5

[7]
A Rare Case of Benign Recurrent Intrahepatic Cholestasis Initially Diagnosed in Middle-age.

Altern Ther Health Med. 2024-12

[8]
Case Report: A Novel Homozygous Variant Identified in a Chinese Patient With Benign Recurrent Intrahepatic Cholestasis-Type 1.

Front Med (Lausanne). 2021-8-18

[9]
Treatment of pruritus with Prometheus dialysis and absorption system in a patient with benign recurrent intrahepatic cholestasis.

Hepatol Res. 2014-10

[10]
Case Report: A Rare Heterozygous Mutation in a BRIC1 Patient: Haploinsufficiency?

Front Med (Lausanne). 2022-6-16

本文引用的文献

[1]
Clinicopathologic Features, Genetics, Treatment, and Long-Term Outcomes in Japanese Children and Young Adults with Benign Recurrent Intrahepatic Cholestasis: A Multicenter Study.

J Clin Med. 2023-9-15

[2]
Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis.

Front Pharmacol. 2023-5-31

[3]
Brain-gut-liver axis: Chronic psychological stress promotes liver injury and fibrosis gut in rats.

Front Cell Infect Microbiol. 2022

[4]
Improvement of cholestatic episodes in patients with benign recurrent intrahepatic cholestasis (BRIC) treated with rifampicin. A long-term follow-up.

Scand J Gastroenterol. 2023-5

[5]
Bile acids and the gut microbiota: metabolic interactions and impacts on disease.

Nat Rev Microbiol. 2023-4

[6]
Clinical phenotype of adult-onset liver disease in patients with variants in ABCB4, ABCB11, and ATP8B1.

Hepatol Commun. 2022-10

[7]
Case Report: A Rare Heterozygous Mutation in a BRIC1 Patient: Haploinsufficiency?

Front Med (Lausanne). 2022-6-16

[8]
Case Report: A Rare Case of Benign Recurrent Intrahepatic Cholestasis-Type 1 With a Novel Heterozygous Pathogenic Variant of .

Front Med (Lausanne). 2022-4-29

[9]
Triggers of benign recurrent intrahepatic cholestasis and its pathophysiology: a review of literature.

Acta Gastroenterol Belg. 2021

[10]
Molecular Pathogenesis of Intrahepatic Cholestasis of Pregnancy.

Can J Gastroenterol Hepatol. 2021

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索